跳至主要内容
欧盟官方标签名称词汇表条目 25271

SARCOSINE

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 0 个有匹配的监管证据:0 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。

0 个市场有证据
已检查的市场
13
有证据的市场
0
证据缺口
13
已解析的标识符
2

已解析的物质身份

CAS:107-97-1
EC:203-538-6
成分索引记录:
SARCOSINE
化妆品功能: SKIN CONDITIONING

Glycine, N-methyl-

1 个匹配或报告的名称
SARCOSINE

跨市场监管证据

此处跟踪的 13 个市场均没有以 SARCOSINE 为名的已导入规则。

这是关于本清单的陈述,而非关于法律的陈述:没有已导入的规则并不能证明某物质获准使用。规则可能以其他名称存在,或以本词汇表条目未载有的 CAS 或 EC 编号存在,或存在于尚未导入的数据集中。

化学身份与性质

CAS 107-97-1 的 PubChem 二维化学结构
CAS 107-97-1PubChem CID 1088

Sarcosine

Sarcosine is a N-alkylglycine that is the N-methyl derivative of glycine. It is an intermediate in the metabolic pathway of glycine. It has a role as a glycine transporter 1 inhibitor, a glycine receptor agonist, a mouse metabolite, an Escherichia coli metabolite and a human metabolite. It is a N-methyl-amino acid, a member of N-methylglycines and a N-alkylglycine. It is a conjugate base of a sarcosinium. It is a conjugate acid of a sarcosinate. It is a tautomer of a sarcosine zwitterion. — ChEBI

IUPAC 名称
2-(methylamino)acetic acid
分子式
C3H7NO2
分子量
89.09 g/mol
精确质量
89.047678466 Da
XLogP3
-2.8
拓扑极性表面积
49.3 Ų
氢键供体
2
氢键受体
3
共价单元
1
已定义的立体中心
0

又称

N-methylglycineSarcosinic acidMethylglycineGlycine, N-methyl-N-Methylaminoacetic acidMethylaminoacetic acid(Methylamino)acetic acidSarcosin
另有 16 个已报告名称
(Methylamino)ethanoic acidAcetic acid, (methylamino)-(methylamino)acetateCHEBI:15611Methylaminoethanoic acidZ711V88R5FN MethylglycineSarcosylate, MagnesiumMETHYL GLYCOCOLLRefChem:181358203-538-62-(methylazaniumyl)acetateSargosine hydrochlorideN-Methyl glycineN-MethylglycocollN-methyl-Glycine
外部数据库标识符

来自其他科学数据库的证据

EMBL-EBI ChEBI
标识符精确匹配CHEBI:15611

sarcosine

A N-alkylglycine that is the N-methyl derivative of glycine. It is an intermediate in the metabolic pathway of glycine.

配方
C3H7NO2
平均质量
89.094 g/mol
单同位素质量
89.04768 Da
形式电荷
0
  • N-methylglycines — is a (CHEBI:21766)
  • N-alkylglycine — is a (CHEBI:66933)
  • N-methyl-amino acid — is a (CHEBI:21760)
  • Escherichia coli metabolite — has role (CHEBI:76971)
  • antipsychotic agent — has role (CHEBI:35476)
  • antidepressant — has role (CHEBI:35469)
  • human metabolite — has role (CHEBI:77746)
  • glycine transporter 1 inhibitor — has role (CHEBI:64588)
  • glycine receptor agonist — has role (CHEBI:64589)
  • mouse metabolite — has role (CHEBI:75771)
  • Escherichia coli metabolite — has role (CHEBI:76971)
  • antipsychotic agent — has role (CHEBI:35476)
  • antidepressant — has role (CHEBI:35469)
  • human metabolite — has role (CHEBI:77746)
  • glycine transporter 1 inhibitor — has role (CHEBI:64588)
  • glycine receptor agonist — has role (CHEBI:64589)
  • mouse metabolite — has role (CHEBI:75771)
  • N-methylglycines — is a (CHEBI:21766)
  • N-alkylglycine — is a (CHEBI:66933)
  • N-methyl-amino acid — is a (CHEBI:21760)
  • sarcosinate — is conjugate acid of (CHEBI:46915)
  • sarcosinium — is conjugate base of (CHEBI:46842)
  • sarcosine zwitterion — is tautomer of (CHEBI:57433)
其他整理的名称
sarcosineN-methylaminoacetic acidL-sarcosineMeGly(methylamino)acetic acidmethylaminoacetic acidMethylamino-acetic acid(methylamino)ethanoic acidN-MethylglycineSarSarcosineSARCOSINEsarcosinic acid
来自此来源的交叉引用
  • CAS: 107-97-1 — KEGG COMPOUND
  • CAS: 107-97-1 — ChemIDplus
  • CAS: 107-97-1 — NIST Chemistry WebBook
  • REGISTRY_NUMBER: 1699442 — Reaxys
  • REGISTRY_NUMBER: 2018 — Gmelin
  • MANUAL_X_REF: C00213 — KEGG COMPOUND
  • MANUAL_X_REF: c0135 — UM-BBD
  • MANUAL_X_REF: HMDB0000271 — HMDB
  • MANUAL_X_REF: SAR — PDBeChem
  • MANUAL_X_REF: Sarcosine — Wikipedia
  • MANUAL_X_REF: SARCOSINE — MetaCyc

映射方: Exact CAS cross-reference in the ChEBI compound record. 来源更新: 2016-01-27. 检索时间: 2026-08-31. 打开来源记录

NIH PubChem PUG-View
标识符精确匹配1088

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou 来源: CAMEO Chemicals
  • Note: This chemical does not meet GHS hazard criteria for 98.7% (149 of 151) of all reports. 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: Not Classified; Reported as not meeting GHS hazard criteria by 149 of 151 companies (only 1.3% companies provided GHS information). For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 151 reports by companies from 3 notifications to the ECHA C&L Inventory.; Reported as not meeting GHS hazard criteria per 149 of 151 reports by companies.; There is 1 notification provided by 2 of 151 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Health Effects: Acyl sarcosines may cause irritation to the skin and eyes. They may also react to produce N-nitrososarcosine, which is believed to be carcinogenic. (A2881) 来源: Toxin and Toxin Target Database (T3DB)
  • Health Effects: Acute Exposure: Can lead to eye and skin irritation. Chronic Exposure: High levels of sarcosine in prostate tissues are associated with aggressive prostate tumors. In this regard, sarcosine appears to function as an oncometabolite. High levels of sarcosine are also seen in patients with sarcosinemia. Sarcosinemia is a rare inborn error of metabolism that is characterized by an increased level of sarcosine (N-methylglycine) in the plasma and urine. The enzymatic block results from a deficiency of sarcosine dehydrogenase (SarDH), a liver mitochondrial matrix enzyme that converts sarcosine into glycine. The disease is mostly characterized by mental delay, cardiomyopathy, deafness and visual disturbance. 来源: Toxin and Toxin Target Database (T3DB)
  • Cosmetic Ingredient Review Conclusion: The CIR Expert Panel concluded that the following ingredients are safe as used in cosmetics when formulated to be non-irritating. The Expert Panel cautions that these ingredients should not be used in cosmetic products in which N-nitroso compounds can be found...Cocoyl Sarcosine... 来源: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Safe for use in cosmetics, with qualifications 来源: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: While acyl sarcosines themselves are not toxic, they are nitrosating agents. Nitrosating agents may decompose and/or react to cause nitrosamine contamination. Nitrosamines are produced from secondary amines and amides in the presence of nitrite ions and are believed to be carcinogenic. The particular nitrosamine produced by acyl sarcosines is N-nitrososarcosine. Once in the body, nitrosamines are activated by cytochrome P-450 enzymes. They are then believed to induce their carcinogenic effects by forming DNA adducts at the N- and O-atoms. (L1889, L1890, A2878, A2879, A2880, A2881) 来源: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: Sarcosine is an oncometabolite. Sarcosine appears to upregulate the expression of the potent oncoprotein called human epidermal growth factor receptor 2 (HER2/neu) in androgen-dependent prostate cancer cells upon exposure to exogenous sarcosine. Thus, sarcosine may induce prostate cancer progression by increased HER2/neu expression. 来源: Toxin and Toxin Target Database (T3DB)
  • Cosmetic Ingredient Review Link: CIR ingredient: Cocoyl Sarcosine 来源: Cosmetic Ingredient Review (CIR)
  • Sources/Uses: Used as an intermediate in synthesis of toothpaste antienzyme agents; [Merck Index] An amino acid intermediate in the metabolism of choline. [ChemIDplus] Used to make antienzyme agents for cosmetics and pharmaceuticals; [NTP] 来源: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Uses: Acyl sarcosines are used as hair-conditioning agents and surfactant-cleansing agents in cosmetics, as well as to improve wetting and penetration of topical pharmaceutical products. Acyl sarcosines and their sodium salts are also used in the metal finishing and processing industries for their crystal modifying, anti-rust, and anti-corrosion properties. (A2881) 来源: Toxin and Toxin Target Database (T3DB)
  • Uses: Sarcosine can be used as a cognitive enhancer and to treat schizophrenia. 来源: Toxin and Toxin Target Database (T3DB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
EMBL-EBI ChEBI精确匹配2026-08-31
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定